$12.14
N/A
Last update: Nov 9, 4:00 PM
Zevra Therapeutics Inc
ZVRANASDAQ
The average analyst price target for Zevra Therapeutics is $23.50, 93.6% above the current price. Of 11 analysts, 11 rate it Buy. Targets range from $17 to $35. The latest change came on Aug 7, 2026, when Guggenheim lowered its price target on Zevra Therapeutics from $24 to $23 and kept a Buy rating.
Price Target Range — 12 Quarters
Analyst Consensus — 11 Analysts
Rating Trend — Last 9 Months
